ClassID:

109900

C12N2710/16661 - CPC Classification

Classification description:

dsDNA viruses; Details; Herpesviridae; Simplexvirus, e.g. human herpesvirus 1, 2 Methods of inactivation or attenuation

Sub-classes:
Recent Application in this class:
#1
20220396779
2022-12-15

VIRAL INACTIVATION METHOD, METHOD FOR PRODUCING DRIED AMNION, AND DRIED AMNION

#2
20170020994
2017-01-26

Materials and methods for the treatment of latent viral infection

#3
20160326498
2016-11-10

Cell strain having increased virus production ability and production method therefor

#4
20150290315
2015-10-15

HSV-1 and HSV-2 vaccines and methods of use thereof

#5
20140314811
2014-10-23

Herpes simplex virus vaccines

#6
20130034586
2013-02-07

Avirulent oncolytic herpes simplex virus strains engineered to counter the innate host response

#7
20120263752
2012-10-18

Herpes simplex virus vaccines

#8
20120114695
2012-05-10

HSV-1 and HSV-2 vaccines and methods of use thereof

#9
20110274661
2011-11-10

Attentuated Herpesvirus Encoding a Mek Pathway Polypeptide

#10
20110236415
2011-09-29

Virulent oncolytic herpes simplex virus strains engineered to counter the innate host response

#11
20110177125
2011-07-21

HSV-1 and HSV-2 vaccines and methods of use thereof

#12
20110052630
2011-03-03

Compositions and methods using herpes simplex virus

#13
20100008944
2010-01-14

HERPES SIMPLEX VIRUS MUTANT AND USES THEREFORE

#14
20090246227
2009-10-01

Methods of use for HSV-1 and HSV-2 vaccines

#15
20090117644
2009-05-07

HSV with a Musashi promoter regulating γ34.5 and ribonucleotide reductase expression

#16
20080206199
2008-08-28

Chimeric Herpes Viruses and Uses Thereof

#17
20080089910
2008-04-17

Attenuated Herpes Simplex Virus Type-2, Vectors Thereof and Immunogenic Compositions Thereof

#18
20060160202
2006-07-20

Artificial chromosomes comprising EHV sequences

#19
20060121522
2006-06-08

Herpes viruses for immune modulation

#20
20060039894
2006-02-23

Avirulent oncolytic herpes simplex virus strains engineered to counter the innate host response

#21
20050249705
2005-11-10

Antitumor agents with the use of HSV

#22
20050112142
2005-05-26

Methods and compositions for treatment and prevention of HSV-2 infections and conditions

#23
16145962
2019-01-22

Method of making a vaccine